Diseases, Conditions, Syndromes

A new study of more than 13 million people in England has found no evidence to suggest mild COVID-19 infection may cause long-term kidney damage. However, patients hospitalized with severe COVID-19 infections are at a high risk of long-term kidney damage, the analysis suggests.

Common viral respiratory infections such as COVID-19, respiratory syncytial virus (RSV) and influenza are linked to an increased short-term risk of stroke and heart attack in adults, new University of Melbourne research has found.

New research reveals how seasonal diseases impact our willingness to follow health measures. People are less likely to follow protective measures when infection levels drop, leading to seasonal surges in disease.

Devices made with cheap strips of paper have outperformed two other testing methods in detecting malaria infection in asymptomatic people in Ghana—a diagnostic advance that could accelerate efforts to eliminate the disease, researchers say.

First described 60 years ago, chronic myoclonus following cerebral anoxia is now known as Lance-Adams syndrome. This is a severe disorder whose mechanisms were, until now, poorly understood. Geoffroy Vellieux, Vincent Navarro, and their colleagues at the Paris Brain Institute now show that this condition originates in the motor cortex. Their findings are published in the journal Neurology.

The U.S. logged fewer than 30 measles cases this week as Ohio health officials confirmed three outbreaks in two counties were over.

The adoption of the WHO Pandemic Agreement by the World Health Assembly on 20 May 2025 was a landmark moment in global health.

An international study has, for the first time, revealed a strong and direct link between the rise of antibiotic-resistant bacteria and universal disinfection procedures applied to patients in intensive care units. Published in The Lancet Microbe, the study calls for a reassessment of health care guidelines on the widespread use of disinfectants.

AI guidance for clinicians aimed at reducing the spread of Clostridioides difficile—a bacteria that can be deadly for sick patients—was deployed for the first time in a hospital setting, according to a University of Michigan-led study published in JAMA Network Open.

Scientists say they have new experimental evidence of a novel role for bilirubin, a natural yellow pigment found in the body, in protecting humans from the worst effects of malaria and potentially other infectious diseases. The findings could advance the search for drugs that mimic the pigment bilirubin, or deliver it to the body to help protect people from severe forms of some infections.